- Our Doctors
- Dr David Kliman
Dr David Kliman
MBBS (Hons), FRACP, FRCPA, Haematologist
For patients/carers
For doctors
MBBS (Hons), FRACP, FRCPA, Haematologist
Locations
Clinical interests
- Blood cancer
Languages
Fluent
- English
- Hebrew / עברית
Biography
Clinical interest in lymphoma, myeloma, leukaemia, cellular therapies, thrombosis and general haematology
David graduated from medicine with honours from Monash University in 2006 and completed joint clinical and laboratory haematology training at Royal North Shore Hospital.
He has completed additional clinical fellowships in malignant haematology and cellular therapies at the BC Cancer Institute in Vancouver, Canada as well as Westmead and St Vincent’s Hospitals in Sydney.
David was appointed as a Staff Specialist with the Malignant Haematology and Stem Cell Transplant Service at the Alfred Hospital in Melbourne in 2019, with an additional honorary consulting service to the lymphoma and myeloma clinic at Monash Health.
In 2021 David returned to Sydney to join the Haematology Department at Royal North Shore Hospital as a Staff Specialist.
David has a broad interest in malignant and non-malignant haematology, with a focus on patient-centred, evidence-based care. His research and education interests are in post-treatment survivorship outcomes and quality-of life.
More information
David is interested in research especially in the areas of haematology, cellular therapies, and transplantation.
- Gottlieb D, Clancy L, Withers B, McGuire H, Luciani F, Singh M, Hughes B, Gloss B, Kliman D, Ma C, Panicker S, Bishop D, Dubosq M, Li Z, Avdic S, Micklethwaite K, Blyth E. Prophylactic antigen-specific T-cells targeting seven viral and fungal pathogens after allogeneic haemopoietic stem cell transplant. Clin Transl Immunology. 2021;10(3).
- Tan J, Das T, Kliman D, Muirhead J, Gorniak M, Kalff A, Walker P, Spencer A. Evaluation of EuroFlow minimal residual disease measurement and donor chimerism monitoring following tandem auto-allogeneic transplantation for multiple myeloma. Bone Marrow Transplant. 2021;56(5):1116-1125.
- Das T, Kipp D, Kliman D, Patil S, Curtis D, O’Brien M, Swain M, Widjada J, Cooke R, Ziino M, Spencer A. Important factors in implementation of lineage-specific chimerism analysis for routine use. Bone Marrow Transplant. 2021;56(4):946-948.
- Cashman H, Mayson E, Kliman D, Kesby J, Bell J, Vachalec S, Withers B, Lavee O, Milliken S, Moore J, Hamad N. An integrated electronic health record facilitates a safer and more efficient rural outreach haematology service. Int J Med. 2021;51(11):1869-1875.
- Kliman D, Nivison-Smith I, Gottlieb D, Hamad N, Kerridge I, Purtill D, Szer J, Ma D. Hematopoietic Stem Cell Transplant Recipients Surviving at Least 2 Years from Transplant Have Survival Rates Approaching Population Levels in the Modern Era of Transplantation. Biol Blood Marrow Transplant. 2020;26(9):1171-1718.
- Pryor, D., Turner, S., Tai, K.-H., Tang, C., Sasso, G., Dreosti, M., Woo, H. H., Wilton, L., & Martin, J. M. (2018). Moderate hypofractionation for prostate cancer: A user’s guide. Journal of Medical Imaging and Radiation Oncology, 62(2), 232-239. Moderate hypofractionation for prostate cancer: A user's guide
- Neville, K., Dreosti, M., Blakey, D., Latham, M., Izard, M. A., Young, S., Graham, G., & O’Brien, P. (2020). Adoption of hypofractionated radiation therapy for early breast cancer in private practice: The GenesisCare experience 2014–2016. Journal of Medical Imaging & Radiation Oncology, 64(1), 127-133. https://doi.org/10.1111/1754-9485.12964
- Hoyne, C., Dreosti, M., Shakeshaft, J., & Baxi, S. (2017). Comparison of treatment techniques for reduction in the submandibular gland dose: A retrospective study. Journal of Medical Radiation Sciences, 64(2), 125-130. Comparison of treatment techniques for reduction in the submandibular gland dose: A retrospective study
- Nguyen, K., Mackenzie, P., Allen, A., Dreosti, M., Morgia, M., Zissiadis, Y., Lamoury, G., & Windsor, A. (2017). Breast Interest Group Faculty of Radiation Oncology: Australian and New Zealand patterns of practice survey on breast radiotherapy. Journal of Medical Imaging & Radiation Oncology, 61(4), 508-516. Breast interest group faculty of radiation oncology: Australian and New Zealand patterns of practice survey on breast radiotherapy
- Roos, D. E., Dreosti, M. V., James, C. L., & Hissaria, P. (2018). Radiotherapy for parotid IgG4-related disease. Journal of Medical Radiation Sciences, 66(1), 66–69. Radiotherapy for parotid IgG4‐related disease
Explore more
Disclaimer:
This website is provided for information purposes only. Nothing on this website is intended to be used as medical advice, or to diagnose, treat, cure or prevent any disease. It should not be used as a substitute for your own health professional's advice. Any medical procedure or treatment carries risks. Before proceeding with treatment, you should discuss the risks and benefits of the treatment with an appropriately qualified health practitioner. Individual treatment outcomes and experiences will vary.